-
1
-
-
35348900749
-
Nonalcoholic fatty liver disease
-
Adams LA, Lindor KD. Nonalcoholic fatty liver disease. Ann Epidemiol 2007;17:863-869.
-
(2007)
Ann Epidemiol
, vol.17
, pp. 863-869
-
-
Adams, L.A.1
Lindor, K.D.2
-
2
-
-
79960029926
-
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
-
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-285.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 274-285
-
-
Vernon, G.1
Baranova, A.2
Younossi, Z.M.3
-
3
-
-
34548761014
-
Liver fat in the metabolic syndrome
-
Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 2007;92:3490-3497.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 3490-3497
-
-
Kotronen, A.1
Westerbacka, J.2
Bergholm, R.3
Pietilainen, K.H.4
Yki-Jarvinen, H.5
-
4
-
-
77952785795
-
Non-alcoholic fatty liver disease from pathogenesis to management: an update
-
Musso G, Gambino R, Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 2010;11:430-445.
-
(2010)
Obes Rev
, vol.11
, pp. 430-445
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
-
5
-
-
4043077961
-
Molecular mediators of hepatic steatosis and liver injury
-
Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147-152.
-
(2004)
J Clin Invest
, vol.114
, pp. 147-152
-
-
Browning, J.D.1
Horton, J.D.2
-
6
-
-
33644827082
-
Overproduction of large VLDL particles is driven by increased liver fat content in man
-
Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006;49:755-765.
-
(2006)
Diabetologia
, vol.49
, pp. 755-765
-
-
Adiels, M.1
Taskinen, M.R.2
Packard, C.3
Caslake, M.J.4
Soro-Paavonen, A.5
Westerbacka, J.6
-
7
-
-
42949178538
-
Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects
-
Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008;134:1369-1375.
-
(2008)
Gastroenterology
, vol.134
, pp. 1369-1375
-
-
Korenblat, K.M.1
Fabbrini, E.2
Mohammed, B.S.3
Klein, S.4
-
8
-
-
84861591910
-
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
-
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592-1609.
-
(2012)
Gastroenterology
, vol.142
, pp. 1592-1609
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
Diehl, A.M.4
Brunt, E.M.5
Cusi, K.6
-
9
-
-
33750606061
-
Long-term follow-up of patients with NAFLD and elevated liver enzymes
-
Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-873.
-
(2006)
Hepatology
, vol.44
, pp. 865-873
-
-
Ekstedt, M.1
Franzen, L.E.2
Mathiesen, U.L.3
Thorelius, L.4
Holmqvist, M.5
Bodemar, G.6
-
10
-
-
75449088414
-
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
-
Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010;51:595-602.
-
(2010)
Hepatology
, vol.51
, pp. 595-602
-
-
Soderberg, C.1
Stal, P.2
Askling, J.3
Glaumann, H.4
Lindberg, G.5
Marmur, J.6
-
11
-
-
58149163149
-
Common variants at 30 loci contribute to polygenic dyslipidemia
-
Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009;41:56-65.
-
(2009)
Nat Genet
, vol.41
, pp. 56-65
-
-
Kathiresan, S.1
Willer, C.J.2
Peloso, G.M.3
Demissie, S.4
Musunuru, K.5
Schadt, E.E.6
-
12
-
-
79959433577
-
Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic finnish men
-
Stancakova A, Paananen J, Soininen P, Kangas AJ, Bonnycastle LL, Morken MA, et al. Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6, 580 nondiabetic finnish men. Diabetes 2011;60:1608-1616.
-
(2011)
Diabetes
, vol.60
, pp. 1608-1616
-
-
Stancakova, A.1
Paananen, J.2
Soininen, P.3
Kangas, A.J.4
Bonnycastle, L.L.5
Morken, M.A.6
-
13
-
-
0036581197
-
Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics
-
Simonen PP, Gylling H, Miettinen TA. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. Obes Res 2002;10:328-335.
-
(2002)
Obes Res
, vol.10
, pp. 328-335
-
-
Simonen, P.P.1
Gylling, H.2
Miettinen, T.A.3
-
14
-
-
1542723726
-
Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men
-
Pihlajamaki J, Gylling H, Miettinen TA, Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004;45:507-512.
-
(2004)
J Lipid Res
, vol.45
, pp. 507-512
-
-
Pihlajamaki, J.1
Gylling, H.2
Miettinen, T.A.3
Laakso, M.4
-
15
-
-
77956849936
-
Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM study
-
Gylling H, Hallikainen M, Pihlajamaki J, Simonen P, Kuusisto J, Laakso M, et al. Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM study. J Lipid Res 2010;51:2422-2427.
-
(2010)
J Lipid Res
, vol.51
, pp. 2422-2427
-
-
Gylling, H.1
Hallikainen, M.2
Pihlajamaki, J.3
Simonen, P.4
Kuusisto, J.5
Laakso, M.6
-
16
-
-
0029845227
-
Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus
-
Laakso M. Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus. Ann Med 1996;28:341-345.
-
(1996)
Ann Med
, vol.28
, pp. 341-345
-
-
Laakso, M.1
-
17
-
-
78649632998
-
Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity
-
Simonen P, Kotronen A, Hallikainen M, Sevastianova K, Makkonen J, Hakkarainen A, et al. Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. J Hepatol 2011;54:153-159.
-
(2011)
J Hepatol
, vol.54
, pp. 153-159
-
-
Simonen, P.1
Kotronen, A.2
Hallikainen, M.3
Sevastianova, K.4
Makkonen, J.5
Hakkarainen, A.6
-
18
-
-
0037453056
-
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
-
Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 2003;100:3077-3082.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 3077-3082
-
-
Listenberger, L.L.1
Han, X.2
Lewis, S.E.3
Cases, S.4
Farese, R.V.5
Ory, D.S.6
-
19
-
-
34250356015
-
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
-
Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007;45:1366-1374.
-
(2007)
Hepatology
, vol.45
, pp. 1366-1374
-
-
Yamaguchi, K.1
Yang, L.2
McCall, S.3
Huang, J.4
Yu, X.X.5
Pandey, S.K.6
-
20
-
-
36349024819
-
A lipidomic analysis of nonalcoholic fatty liver disease
-
Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007;46:1081-1090.
-
(2007)
Hepatology
, vol.46
, pp. 1081-1090
-
-
Puri, P.1
Baillie, R.A.2
Wiest, M.M.3
Mirshahi, F.4
Choudhury, J.5
Cheung, O.6
-
21
-
-
61849095626
-
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
-
Caballero F, Fernandez A, De Lacy AM, Fernandez-Checa JC, Caballeria J, Garcia-Ruiz C. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol 2009;50:789-796.
-
(2009)
J Hepatol
, vol.50
, pp. 789-796
-
-
Caballero, F.1
Fernandez, A.2
De Lacy, A.M.3
Fernandez-Checa, J.C.4
Caballeria, J.5
Garcia-Ruiz, C.6
-
22
-
-
80053612479
-
Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis
-
1403.e1-5
-
Van Rooyen DM, Larter CZ, Haigh WG, Yeh MM, Ioannou G, Kuver R, et al. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology 2011;141:1393-403, 1403.e1-5.
-
(2011)
Gastroenterology
, vol.141
, pp. 1393-1403
-
-
Van Rooyen, D.M.1
Larter, C.Z.2
Haigh, W.G.3
Yeh, M.M.4
Ioannou, G.5
Kuver, R.6
-
23
-
-
84860469242
-
Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease
-
Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab 2012;15:665-674.
-
(2012)
Cell Metab
, vol.15
, pp. 665-674
-
-
Min, H.K.1
Kapoor, A.2
Fuchs, M.3
Mirshahi, F.4
Zhou, H.5
Maher, J.6
-
24
-
-
77956403317
-
Cholesterol absorption decreases after roux-en-Y gastric bypass but not after gastric banding
-
Pihlajamaki J, Gronlund S, Simonen M, Kakela P, Moilanen L, Paakkonen M, et al. Cholesterol absorption decreases after roux-en-Y gastric bypass but not after gastric banding. Metabolism 2009;59:66-72.
-
(2009)
Metabolism
, vol.59
, pp. 66-72
-
-
Pihlajamaki, J.1
Gronlund, S.2
Simonen, M.3
Kakela, P.4
Moilanen, L.5
Paakkonen, M.6
-
25
-
-
84857355693
-
Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans
-
Pihlajamaki J, Kuulasmaa T, Kaminska D, Simonen M, Karja V, Gronlund S, et al. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. J Hepatol 2012;56:663-670.
-
(2012)
J Hepatol
, vol.56
, pp. 663-670
-
-
Pihlajamaki, J.1
Kuulasmaa, T.2
Kaminska, D.3
Simonen, M.4
Karja, V.5
Gronlund, S.6
-
26
-
-
0033200054
-
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
-
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 2467-2474
-
-
Brunt, E.M.1
Janney, C.G.2
Di Bisceglie, A.M.3
Neuschwander-Tetri, B.A.4
Bacon, B.R.5
-
27
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
-
28
-
-
0021813187
-
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
29
-
-
0032821965
-
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
-
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.
-
(1999)
Diabetes Care
, vol.22
, pp. 1462-1470
-
-
Matsuda, M.1
DeFronzo, R.A.2
-
30
-
-
0025156823
-
Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population
-
Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990;131:20-31.
-
(1990)
Am J Epidemiol
, vol.131
, pp. 20-31
-
-
Miettinen, T.A.1
Tilvis, R.S.2
Kesaniemi, Y.A.3
-
31
-
-
40949164211
-
The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes
-
Simonen P, Gylling H, Miettinen TA. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Atherosclerosis 2008;197:883-888.
-
(2008)
Atherosclerosis
, vol.197
, pp. 883-888
-
-
Simonen, P.1
Gylling, H.2
Miettinen, T.A.3
-
32
-
-
0023865658
-
Cholesterol metabolism during ketoconazole treatment in man
-
Miettinen TA. Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 1988;29:43-51.
-
(1988)
J Lipid Res
, vol.29
, pp. 43-51
-
-
Miettinen, T.A.1
-
33
-
-
56749096610
-
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
-
Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461-1465.
-
(2008)
Nat Genet
, vol.40
, pp. 1461-1465
-
-
Romeo, S.1
Kozlitina, J.2
Xing, C.3
Pertsemlidis, A.4
Cox, D.5
Pennacchio, L.A.6
-
34
-
-
77952563455
-
Liver fat in the pathogenesis of insulin resistance and type 2 diabetes
-
Yki-Jarvinen H. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis 2010;28:203-209.
-
(2010)
Dig Dis
, vol.28
, pp. 203-209
-
-
Yki-Jarvinen, H.1
-
35
-
-
33748792007
-
Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands
-
Yang C, McDonald JG, Patel A, Zhang Y, Umetani M, Xu F, et al. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem 2006;281:27816-27826.
-
(2006)
J Biol Chem
, vol.281
, pp. 27816-27826
-
-
Yang, C.1
McDonald, J.G.2
Patel, A.3
Zhang, Y.4
Umetani, M.5
Xu, F.6
-
36
-
-
66549124438
-
Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line
-
Rodriguez-Acebes S, de la Cueva P, Fernandez-Hernando C, Ferruelo AJ, Lasuncion MA, Rawson RB, et al. Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line. Biochem J 2009;420:305-315.
-
(2009)
Biochem J
, vol.420
, pp. 305-315
-
-
Rodriguez-Acebes, S.1
de la Cueva, P.2
Fernandez-Hernando, C.3
Ferruelo, A.J.4
Lasuncion, M.A.5
Rawson, R.B.6
-
37
-
-
0034741599
-
Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis
-
Waterham HR, Koster J, Romeijn GJ, Hennekam RC, Vreken P, Andersson HC, et al. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 2001;69:685-694.
-
(2001)
Am J Hum Genet
, vol.69
, pp. 685-694
-
-
Waterham, H.R.1
Koster, J.2
Romeijn, G.J.3
Hennekam, R.C.4
Vreken, P.5
Andersson, H.C.6
-
38
-
-
35148813852
-
Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol
-
Heverin M, Meaney S, Brafman A, Shafir M, Olin M, Shafaati M, et al. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol. Arterioscler Thromb Vasc Biol 2007;27:2191-2197.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 2191-2197
-
-
Heverin, M.1
Meaney, S.2
Brafman, A.3
Shafir, M.4
Olin, M.5
Shafaati, M.6
-
39
-
-
10344229445
-
Regulation of cellular response to oncogenic and oxidative stress by seladin-1
-
Wu C, Miloslavskaya I, Demontis S, Maestro R, Galaktionov K. Regulation of cellular response to oncogenic and oxidative stress by seladin-1. Nature 2004;432:640-645.
-
(2004)
Nature
, vol.432
, pp. 640-645
-
-
Wu, C.1
Miloslavskaya, I.2
Demontis, S.3
Maestro, R.4
Galaktionov, K.5
-
40
-
-
46349096632
-
3beta-hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis
-
Lu X, Kambe F, Cao X, Kozaki Y, Kaji T, Ishii T, et al. 3beta-hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology 2008;149:3267-3273.
-
(2008)
Endocrinology
, vol.149
, pp. 3267-3273
-
-
Lu, X.1
Kambe, F.2
Cao, X.3
Kozaki, Y.4
Kaji, T.5
Ishii, T.6
-
41
-
-
37849018203
-
Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress
-
Kuehnle K, Crameri A, Kalin RE, Luciani P, Benvenuti S, Peri A, et al. Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Mol Cell Biol 2008;28:539-550.
-
(2008)
Mol Cell Biol
, vol.28
, pp. 539-550
-
-
Kuehnle, K.1
Crameri, A.2
Kalin, R.E.3
Luciani, P.4
Benvenuti, S.5
Peri, A.6
-
42
-
-
84860334010
-
Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus
-
Rodgers MA, Villareal VA, Schaefer EA, Peng LF, Corey KE, Chung RT, et al. Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus. J Am Chem Soc 2012;134:6896-6899.
-
(2012)
J Am Chem Soc
, vol.134
, pp. 6896-6899
-
-
Rodgers, M.A.1
Villareal, V.A.2
Schaefer, E.A.3
Peng, L.F.4
Corey, K.E.5
Chung, R.T.6
-
43
-
-
73649087627
-
Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase
-
Nishimura T, Kohara M, Izumi K, Kasama Y, Hirata Y, Huang Y, et al. Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase. J Biol Chem 2009;284:36442-36452.
-
(2009)
J Biol Chem
, vol.284
, pp. 36442-36452
-
-
Nishimura, T.1
Kohara, M.2
Izumi, K.3
Kasama, Y.4
Hirata, Y.5
Huang, Y.6
-
44
-
-
43749092373
-
Dysmetabolic changes associated with HCV: a distinct syndrome?
-
Lonardo A, Loria P, Carulli N. Dysmetabolic changes associated with HCV: a distinct syndrome? Intern Emerg Med 2008;3:99-108.
-
(2008)
Intern Emerg Med
, vol.3
, pp. 99-108
-
-
Lonardo, A.1
Loria, P.2
Carulli, N.3
-
45
-
-
80053053350
-
The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption
-
Miettinen TA, Gylling H, Nissinen MJ. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr Metab Cardiovasc Dis 2011;21:765-769.
-
(2011)
Nutr Metab Cardiovasc Dis
, vol.21
, pp. 765-769
-
-
Miettinen, T.A.1
Gylling, H.2
Nissinen, M.J.3
|